Now approved for use with needle and cannula
Now approved for use with needle and cannula
DESIGNED 4 MORE POSSIBILITIES WITH an optimized 1.2mL syringe
Natural volume for moderate to severe dynamic folds and deeper deficits
Offered in an optimized 1.2 mL syringe
Natural volume for moderate to severe dynamic folds and deeper deficits
May be appropriate for patients who:
- Need correction with a deeper-placed filler
- Desire a natural look and enhanced volume without obvious ridges
Results that last up to
15 months*
Results that last up to 15 months*
Patient was treated with 3.6 mL RHA® 4: 1.4 mL for direct nasolabial fold correction, 1.6 mL for indirect nasolabial fold correction, and 0.6 mL in oral commissures. Images captured before and two weeks after treatment. Results may vary.
*Clinical effectiveness and safety were demonstrated in a 15-month clinical trial for the treatment of moderate to severe nasolabial folds.
RHA® 4 INJECTION
Indicated for injection in the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds, in adults aged 22 years or older
- Thin gauge needle (27 G x ½”) or cannula (25 G x 2″)
- Inserted into the deep dermis to superficial subcutaneous tissue at a 15° to 30° angle with needle, and a 30° angle with cannula
Previous
Next
OTHER PRODUCTS
